Skip to main content
Canna~Fangled Abstracts

An overview of the non-procedural treatment options for peripheral neuropathic pain

By November 7, 2024November 14th, 2024No Comments

Review

doi: 10.1002/mus.28286.

Online ahead of print.
Affiliations 

Abstract

Peripheral neuropathic pain is common in patients with peripheral nerve injury and can significantly impact both their function and quality of life. There is a wide variety of non-interventional treatment approaches, including pharmacologic therapy, physical/occupational therapy, modalities (therapeutic, mechanical, thermal, etc.), psychology, and lifestyle modification. First line pharmacologic therapy for peripheral neuropathic pain includes gabapentinoids, tricyclic antidepressants, and serotonin-norepinephrine reuptake inhibitors. Other classes of medications, such as topical treatments, opioids, and cannabinoids, have more limited usefulness in treatment but remain part of a treatment regimen. Physical and occupational therapy, psychological interventions, and lifestyle medicine are important adjuncts in the treatment and prevention of future peripheral neuropathic pain. The strength of the evidence supporting each intervention varies, with that for pharmacologic intervention being the strongest. A combination of these options tailored to the individual needs of the patient likely will result in the best treatment outcome for peripheral neuropathic pain.

Keywords: chronic neuropathic pain; nerve injury; neuropathic pain; nociception; peripheral nerve injury.

PubMed Disclaimer

References

REFERENCES

    1. Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD‐11: chronic neuropathic pain. Pain. 2019;160(1):53‐59. doi:10.1097/J.PAIN.0000000000001365
    1. Van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654‐662. doi:10.1016/J.PAIN.2013.11.013
    1. Marchettini P, Lacerenza M, Mauri E, Marangoni C. Painful peripheral neuropathies. Curr Neuropharmacol. 2006;4(3):175‐181. doi:10.2174/157015906778019536
    1. Torrance N, Ferguson JA, Afolabi E, et al. Neuropathic pain in the community: more under‐treated than refractory? Pain. 2013;154(5):690‐699. doi:10.1016/J.PAIN.2012.12.022
    1. Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract. 2007;24(5):481‐485. doi:10.1093/FAMPRA/CMM042

Publication types

LinkOut – more resources

  • Full Text Sources


Leave a Reply